{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:15:02Z","timestamp":1786990502907,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology","doi-asserted-by":"publisher","award":["BT\/PR49857\/MED\/32\/850\/2023"],"award-info":[{"award-number":["BT\/PR49857\/MED\/32\/850\/2023"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["EM\/DEV\/SG\/149\/2497\/2023"],"award-info":[{"award-number":["EM\/DEV\/SG\/149\/2497\/2023"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019597","name":"Advanced Instrumentation Research Facility","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019597","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100029379","name":"Arthur N. Rupe Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100029379","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004541","name":"Ministry of Education, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017896","name":"Jawaharlal Nehru University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017896","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ijbiomac.2025.148463","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T15:17:23Z","timestamp":1761146243000},"page":"148463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"P1","title":["Reversal of hypoxia-induced chemoresistance using hemoglobin-loaded polycaprolactone nanoparticles"],"prefix":"10.1016","volume":"332","author":[{"given":"Harsh A.","family":"Gandhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaydeep","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148463_bb0005","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10555-007-9055-1","article-title":"Hypoxia in cancer: significance and impact on clinical outcome","volume":"26","author":"Vaupel","year":"2007","journal-title":"Cancer Metastasis Rev."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148463_bb0010","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrc1367","article-title":"Exploiting tumour hypoxia in cancer treatment","volume":"4","author":"Brown","year":"2004","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148463_bb0015","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","article-title":"Hypoxia-inducible factors in physiology and medicine","volume":"148","author":"Semenza","year":"2012","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148463_bb0020","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/cdd.2014.143","article-title":"Autosis and autophagic cell death: the dark side of autophagy","volume":"22","author":"Liu","year":"2015","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148463_bb0025","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12411","article-title":"Autophagy regulates cisplatin-induced stemness and chemoresistance via the upregulation of CD44, ABCB1 and ADAM17 in oral squamous cell carcinoma","volume":"51","author":"Naik","year":"2018","journal-title":"Cell Prolif."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148463_bb0030","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1158\/0008-5472.CAN-11-3831","article-title":"Hypoxia-induced autophagy promotes tumor cell survival and adaptation to antiangiogenic treatment in glioblastoma","volume":"72","author":"Hu","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.148463_bb0035","first-page":"53","article-title":"Ovarian tumor microenvironment contributes to tumor progression and chemoresistance","volume":"7","author":"Ponton-Almodovar","year":"2024","journal-title":"Cancer Drug Resist."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148463_bb0040","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00432-009-0675-4","article-title":"Hypoxia induced paclitaxel resistance in human ovarian cancers via hypoxia-inducible factor 1alpha","volume":"136","author":"Huang","year":"2010","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148463_bb0045","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1081\/BIO-200046659","article-title":"Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant to in vivo oxygen delivery","volume":"33","author":"Riess","year":"2005","journal-title":"Artif. Cells Blood Substit. Immobil. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2025.148463_bb0050","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3389\/fchem.2020.00358","article-title":"Oxygen-sufficient nanoplatform for chemo-sonodynamic therapy of hypoxic tumors","volume":"8","author":"Huang","year":"2020","journal-title":"Front. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148463_bb0055","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1364\/BOE.499286","article-title":"Relief of tumor hypoxia using a nanoenzyme amplifies NIR-II photoacoustic-guided photothermal therapy","volume":"15","author":"Xue","year":"2023","journal-title":"Biomed. Opt. Express"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148463_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0269939","article-title":"Scalable production and complete biophysical characterization of poly(ethylene glycol) surface conjugated liposome encapsulated hemoglobin (PEG-LEH)","volume":"17","author":"Banerjee","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2025.148463_bb0065","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-024-02606-1","article-title":"Nanomaterial-related hemoglobin-based oxygen carriers, with emphasis on liposome and nano-capsules, for biomedical applications: current status and future perspectives","volume":"22","author":"Zhu","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"20","key":"10.1016\/j.ijbiomac.2025.148463_bb0070","doi-asserted-by":"crossref","first-page":"9200","DOI":"10.1021\/acs.chemmater.2c02190","article-title":"Metal-phenolic networks as broad-spectrum antioxidant coatings for hemoglobin nanoparticles working as oxygen carriers","volume":"34","author":"Chen","year":"2022","journal-title":"Chem. Mater."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.148463_bb0075","doi-asserted-by":"crossref","DOI":"10.1002\/anbr.202300019","article-title":"Silk fibroin particles as carriers in the development of hemoglobin-based oxygen carriers","volume":"3","author":"Pacheco","year":"2023","journal-title":"Adv. NanoBiomed Res."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148463_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e15878","article-title":"Biocompatibility of the oxygen carrier polymerized human hemoglobin towards HepG2\/C3A cells","volume":"9","author":"Chen","year":"2023","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148463_bb0085","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202100683","article-title":"Hemoglobin-inorganic hybrid nanoflowers with different metal ions as potential oxygen carrying systems","volume":"19","author":"Gulmez","year":"2022","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.ijbiomac.2025.148463_bb0090","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3762\/bjnano.13.8","article-title":"Bacterial safety study of the production process of hemoglobin-based oxygen carriers","volume":"13","author":"Steffen","year":"2022","journal-title":"Beilstein J. Nanotechnol."},{"key":"10.1016\/j.ijbiomac.2025.148463_bb0095","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.partic.2021.08.010","article-title":"Artificial oxygen carriers, from nanometer- to micrometer-sized particles, made of hemoglobin composites substituting for red blood cells","volume":"64","author":"Matsuhira","year":"2022","journal-title":"Particuology"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148463_bb0100","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1021\/acsbiomaterials.1c00424","article-title":"Preparation of artificial red blood cells (hemoglobin vesicles) using the rotation\u2013revolution mixer for high encapsulation efficiency","volume":"7","author":"Kure","year":"2021","journal-title":"ACS Biomater Sci. Eng."},{"issue":"21","key":"10.1016\/j.ijbiomac.2025.148463_bb0105","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1182\/bloodadvances.2022007977","article-title":"First-in-human phase 1 trial of hemoglobin vesicles as artificial red blood cells developed for use as a transfusion alternative","volume":"6","author":"Azuma","year":"2022","journal-title":"Blood Adv."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.148463_bb0110","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.trecan.2016.10.016","article-title":"Hypoxia-inducible factors: master regulators of cancer progression","volume":"2","author":"Schito","year":"2016","journal-title":"Trends in cancer"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148463_bb0115","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3390\/pharmaceutics13020191","article-title":"Polycaprolactone nanoparticles as promising candidates for nanocarriers in novel nanomedicines","volume":"13","author":"\u0141ukasiewicz","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2025.148463_bb0120","first-page":"69","article-title":"Macrophage membrane-coated nanovesicles for dual-targeted drug delivery to inhibit tumor and induce macrophage polarization","volume":"23","author":"Huang","year":"2022","journal-title":"Bioact. Mater."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148463_bb0125","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13578","article-title":"New insights into the interaction between m6A modification and lncRNA in cancer drug resistance","volume":"57","author":"Jin","year":"2024","journal-title":"Cell Prolif."},{"key":"10.1016\/j.ijbiomac.2025.148463_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121821","article-title":"Biomimetic cell membrane-coated glucose\/oxygen-exhausting nanoreactor for remodeling tumor microenvironment in targeted hypoxic tumor therapy","volume":"290","author":"Guo","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2025.148463_bb0135","article-title":"Dysregulation of calcium homeostasis in cancer and its role in chemoresistance","volume":"7","author":"Kumari","year":"2024","journal-title":"Cancer Drug Resist."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148463_bb0140","article-title":"Bioengineer mesenchymal stem cell for treatment of glioma by IL-12 mediated microenvironment reprogramming and nCD47-SLAMF7 mediated phagocytosis regulation of macrophages","volume":"10","author":"Man Li","year":"2024","journal-title":"Sci. Adv."},{"issue":"16","key":"10.1016\/j.ijbiomac.2025.148463_bb0145","article-title":"Antigen\/adjuvant-free liposome induces adjuvant effects for enhancing cancer immunotherapy","volume":"11","author":"Guo","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ijbiomac.2025.148463_bb0150","first-page":"133","article-title":"Innovative utilization of cell membrane-coated nanoparticles in precision cancer therapy","volume":"7","author":"He","year":"2024","journal-title":"Cancer Drug Resist."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.148463_bb0155","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation","volume":"8","author":"Mosser","year":"2008","journal-title":"Nat. Rev. Immunol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025090208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025090208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:39:50Z","timestamp":1773272390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025090208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":31,"alternative-id":["S0141813025090208"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.148463","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reversal of hypoxia-induced chemoresistance using hemoglobin-loaded polycaprolactone nanoparticles","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.148463","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"148463"}}